Bridging Medicine, Empowering Health

As a leading multinational healthcare enterprise, Tokyo Daiwa integrate advanced medical technologies, professional health management, and premium wellness products to foster cross-border collaboration and holistic well-being.

Healthcare expertise, health mission

In Japan, medicine is “the art of humanity”. We work with the spirit of making healthcare our core, improving lives through precise quality and constant innovation.

Hospital & Clinic Management

Operating medical facilities with Japanese standards of quality, safety, and patient-centered care.

Evidence-Based Supplement Development

Creating high-quality health supplements backed by scientific research and compliant with strict regulations.

Cross-Border Medical Collaboration

Connecting global healthcare resources through technology transfer, specialist exchanges, and international treatment networks.

Products

Creating high-quality health supplements backed by scientific research and compliant with strict regulations.

NMN 50000

NMN 50000

A next-generation anti-aging supplement delivering nanonized deazoflavin and high-purity NMN daily. Expertly crafted in hand-hammered copper containers for premium quality.

5-Deazaflavin ReUP

5-Deazaflavin ReUP

The strongest known NAD+ booster, hailed as the “ultimate NMN”, and expertly combined with CoQ10 and PQQ for powerful anti-aging synergy.

NAMAKO

NAMAKO Supplement

Rich in sea cucumber saponins, organic selenium, mucopolysaccharides and other longevity nutrients, and hailed by Japanese nutritionists as “NMN in ocean.”

Lacpia

Lacpia Miyairi bacteria

The world's first short-chain fatty acid supplement, featuring a unique Clostridium butyricum production process to revolutionize gut microbiota and improve intestinal microecological balance.

R & D

We view research and development as the foundation of our mission to advance health and well-being through science, combining innovation with responsibility to address society’s evolving medical needs.

research and development
Tokyo Daiwa advances research and development through patient-focused innovation, open collaboration, digital transformation, and ethical sustainability, in order to deliver breakthrough therapies that meet unmet medical needs while minimizing environmental impact.
Patient-Centric Innovation

We drives innovation guided by patient needs, focusing on developing solutions for unmet medical conditions and improving quality of life.

Open Innovation & Collaboration

We foster open innovation by partnering with universities, research institutes, and global biotech firms to accelerate discovery and translate science into value.

Digital Transformation in R&D 

Our R&D integrates data science, AI, and real-world evidence to enhance drug discovery efficiency and clinical decision-making.

Ethical & Sustainable R&D

We uphold research ethics, transparency, and environmental responsibility, promoting sustainable laboratories and responsible innovation across the product life cycle.

Advantages

Tokyo Daiwa’s competitive advantage lies in its strong domestic medical network in Japan, uncompromising product quality under GMP standards, and its strategic role as a cross-border bridge connecting Japan and international healthcare markets.

Strong Domestic Foundation in Japan

Strong Domestic Foundation in Japan

Tokyo Daiwa leverages its deep roots in Japan’s medical industry and extensive doctor–clinic network to build trusted, localized partnerships.

Commitment to Quality and Safety

Commitment to Quality and Safety

All products are produced under Japan’s GMP standards to ensure the highest levels of safety, quality, and efficacy.

Global perspective and strategic bridge role

Global Perspective and Strategic Bridge Role

With cross-border healthcare expertise, the company acts as a strategic bridge between China and Japan, driving efficient and value-focused collaboration.

Sustainability

Tokyo Daiwa is committed to achieving carbon neutrality by 2050, advancing a circular economy, ensuring the safety and stable supply of medicines, strengthening supply-chain decarbonization, and upholding ESG governance as part of its comprehensive sustainability mission.

Climate Action and Carbon Neutrality Goals

We are committed to achieving net-zero emissions across our entire value chain by 2050 through Scope 1–3 reduction targets.

Read More

Green Packaging and Circular Resource Use

We actively reduce plastic waste by adopting recyclable, bio-based materials and industry-shared circular packaging solutions.

Read More

Product Quality, Patient Safety, and Stable Supply

We develop innovative, low-environmental-impact medicines by placing patient voices and rigorous ethical standards at the heart of our R&D.

Read More

Sustainable Supply Chain and Logistics Management

We ensure end-to-end sustainability by optimizing logistics, using fuel-efficient transport, and enforcing strict ESG standards across our entire supply chain.

Read More

Employee Training and Broader Social Responsibility

We empower every employee with ongoing training in climate action, research ethics, and inclusion while promoting fair pricing and global access to medicines.

Read More



About Tokyo Daiwa

  • Tokyo Daiwa
  • Mission Statement
  • Vision & Values
  • Health Philosophy
  • Business Fields

Products

  • NMN 50000
  • 5-Deazaflavin ReUP
  • NAMAKO Supplement
  • Lacpia Miyairi bacteria

Clinic and Services

  • Clinics
  • International Services

Sustainability

  • Climate
  • Recyclable
  • Safety
  • Supply Chain
  • Social Responsibility

© Copyright 2025 Tokyo Daiva - All Rights Reserved